Got $5,000? This Growth Stock Could Triple Before 2026
While you've probably never heard of it, BioDelivery Sciences International (NASDAQ: BDSI) is an expert at acquiring and commercializing technologies and therapies for severe pain. With a trio of drugs on the market and a patented slow-release biofilm technology for administering them, BDSI is both profitable and growing.
As growth investors everywhere know, that isn't always enough to drive a stock to triple, so let's take a closer look at whether this company has what it takes to be worth a $5,000 investment.
Image source: Getty Images.
Source Fool.com
